In addition to examining expression in normal and tumour tissue in this series, we also sought to examine expression in relation to preneoplasia, histology, and clinical outcome, in an attempt to further characterise the expression of S100A2 in NSCLC. Here, S100A2 is linked to non-small cell lung carcinoma.